APA (7th ed.) Citation

Haagensen, E. J., Thomas, H. D., Wilson, I., Harnor, S. J., Payne, S. L., Rennison, T., . . . Newell, D. R. The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Haagensen, Emma J., Huw D. Thomas, Ian Wilson, Suzannah J. Harnor, Sara L. Payne, Tommy Rennison, Kate M. Smith, Ross J. Maxwell, and David R. Newell. The Enhanced in Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-bearing Mice. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Haagensen, Emma J., et al. The Enhanced in Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-bearing Mice. Public Library of Science (PLoS).